Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients

Fig. 3

Nomogram for predicting CRC patient outcomes. Nomograms conveyed the results of prognostic models using clinicopathological characteristics and pretreatment inflammatory biomarkers to predict OS (a) and DFS (b) of patients with CRC. The Harrell’s c-indexes for OS and DFS prediction were 0.819 (95% CI: 0.806–0.832) and 0.835 (95% CI: 0.822–0.849), respectively

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us